Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Steven C. Ziesmer"'
Supplementary Figure Legends 1-2 from Malignant B Cells Skew the Balance of Regulatory T Cells and TH17 Cells in B-Cell Non-Hodgkin's Lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::216de5ab819433e06ea8343e8ed8748e
https://doi.org/10.1158/0008-5472.22377714
https://doi.org/10.1158/0008-5472.22377714
Supplementary Figure 2 from Malignant B Cells Skew the Balance of Regulatory T Cells and TH17 Cells in B-Cell Non-Hodgkin's Lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75de8575214ee8b11c6d374a941c2922
https://doi.org/10.1158/0008-5472.22377717
https://doi.org/10.1158/0008-5472.22377717
Supplementary Figure 1 from Malignant B Cells Skew the Balance of Regulatory T Cells and TH17 Cells in B-Cell Non-Hodgkin's Lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e92287bb9ba1fa34e89ac1b002c5b6f
https://doi.org/10.1158/0008-5472.22377720
https://doi.org/10.1158/0008-5472.22377720
Autor:
Zhi-Zhang Yang, Deanna M Grote, Steven C Ziesmer, Bing Xiu, Nicole R Yates, Frank J Secreto, Lucy S Hodge, Thomas E Witzig, Anne J Novak, Stephen M Ansell
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e59456 (2013)
While the effect of TGF-β on malignant B cells in non-Hodgkin lymphoma (NHL) has been previously evaluated, studies to specifically define the role of TGF-β in tumor immunity in B-cell NHL are limited. We found that soluble TGF-β, secreted by both
Externí odkaz:
https://doaj.org/article/8bc3e772970d465d8e27b1058840d1e1
Autor:
Steven C. Ziesmer, Brian K. Link, William R. Macon, Oliver W. Press, Michael LeBlanc, Sergei Syrbu, Thomas E. Witzig, Susan L. Slager, Stephen M. Ansell, Muhammad A. Mir, Jonathan W. Friedberg, Anne J. Novak, James R. Cerhan, Thomas M. Habermann, Matthew J. Maurer
Publikováno v:
Blood. 125:992-998
Serum cytokines and chemokines may reflect tumor biology and host response in follicular lymphoma (FL). To determine whether the addition of these biological factors may further refine prognostication, 30 cytokines and chemokines were measured in pre
Autor:
Thomas M. Lanigan, Thomas E. Witzig, Alexandra C. Hristov, Robert Briski, Linda Wellik, David A. Wada, Ye Lu, Mark R. Pittelkow, Tianjiao Wang, Ryan A. Wilcox, Megan S. Lim, Andrew L. Feldman, Thomas M. Habermann, Avery Polk, Nathanael G. Bailey, Dafydd G. Thomas, Kay M. Ristow, Steven C. Ziesmer, Stephen M. Ansell
Publikováno v:
Blood. 123:3007-3015
The cell of origin and the tumor microenvironment’s role remain elusive for the most common peripheral T-cell lymphomas (PTCLs). As macrophages promote the growth and survival of malignant T cells and are abundant constituents of the tumor microenv
Autor:
Lucy S. Hodge, Anne J. Novak, Stephen M. Ansell, Danielle M. Yates, Bing Xiu, Tammy Price-Troska, Steven C. Ziesmer, Zhi-Zhang Yang, Deanna M. Grote
Publikováno v:
Leukemia. 28:1872-1884
Transforming growth factor beta (TGF-β) has an important role in mediating T-cell suppression in B-cell non-Hodgkin lymphoma (NHL). However, the underlying mechanism responsible for TGF-β-mediated inhibition of effector memory T (Tm) cells is large
Autor:
Frank J. Secreto, Anne J. Novak, Zhi Zhang Yang, Stephen M. Ansell, Steven C. Ziesmer, Lucy S. Hodge
Publikováno v:
Blood. 123:1055-1058
Activation of the Janus kinase family/signal transducer and activator of transcription (JAK/STAT) signaling pathway has been associated with the pathogenesis and progression of both solid and hematologic malignancies. We have detected constitutive ac
Autor:
James R. Cerhan, Susan L. Slager, Lucy S. Hodge, Anne J. Novak, Stephen M. Ansell, Preethi Reddy Marri, Steven C. Ziesmer, Thomas M. Habermann, Matthew J. Maurer, Brian K. Link
Publikováno v:
Clinical Cancer Research. 19:6812-6819
Purpose: Although the International Prognostic Score (IPS) is the gold standard for risk-stratifying patients with classical Hodgkin lymphoma (cHL), these criteria do not accurately predict outcome. As cytokines are critically involved in driving cHL
Autor:
Yogesh K. Mariappan, Kevin J. Glaser, Stephen M. Ansell, Steven C. Ziesmer, Brian Reuland, Rickey E. Carter, Jun Chen, Kay M. Pepin, Kiaran P. McGee, Richard L. Ehman
Publikováno v:
Magnetic Resonance in Medicine. 71:1834-1840
Purpose: The overall goal is to develop magnetic resonance elastography derived shear stiffness as a biomarker for the early identification of chemotherapy response, allowing dose, agent type and treatment regimen to be tailored on a per patient basi